Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|June 1, 1997
Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patientsV Heinemann, D Bosse, U Jehn, et al.Antimicrobial Agents and Chemotherapy|April 1, 1997
Serum pharmacology of amphotericin B applied in lipid emulsionsV Heinemann, B Kähny, U Jehn, et al.Blood|March 1, 1989
Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative GroupR Zittoun, U Jehn, D Fière, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia GroupB Löwenberg, R Zittoun, H Kerkhofs, et al.Haematology and Blood Transfusion|January 1, 1990
A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative GroupU Jehn, R Zittoun, S Suciu, et al.European Journal of Cancer & Clinical Oncology|November 1, 1988
Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase II studyR Willemze, U Jager, U Jehn, et al.Cancer|August 1, 1986
A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTCM Hayat, U Jehn, R Willemze, et al.Leukemia|June 9, 1999
Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemiaE Archimbaud, U Jehn, X Thomas, et al.Blood|May 15, 1989
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantationE Holler, H J Kolb, E Hiller, et al.Lipids|November 1, 1987
Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitroH D Schick, W E Berdel, M Fromm, et al.Pageof 8